Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 16 studies. P1096: Phase 1 Study of Live Attenuated Recombinant (cp) 45 Human Parainfluenza Type 3 Vaccine DAIDS Number 11796 Research Area Vaccine Study Status Concluded P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded P1059: Phase I Trial of Recombinant Vaccines in HIV+ Young Adults DAIDS Number 10051 Research Area Other Study Status Concluded P1005: T-20 in HIV-1 Infected Children. DAIDS Number 10314 Research Area Other Study Status Concluded ATN 052: Adolescent Population Genetics and Immune Response to Hepatitis B Vaccination DAIDS Number 10368 Research Area Other Study Status Concluded Pagination Previous page Prev Page 1 Current page 2
P1096: Phase 1 Study of Live Attenuated Recombinant (cp) 45 Human Parainfluenza Type 3 Vaccine DAIDS Number 11796 Research Area Vaccine Study Status Concluded
P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded
P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded
P1059: Phase I Trial of Recombinant Vaccines in HIV+ Young Adults DAIDS Number 10051 Research Area Other Study Status Concluded
P1005: T-20 in HIV-1 Infected Children. DAIDS Number 10314 Research Area Other Study Status Concluded
ATN 052: Adolescent Population Genetics and Immune Response to Hepatitis B Vaccination DAIDS Number 10368 Research Area Other Study Status Concluded
